Intentar ORO - Gratis

Home
The Indian Express Ltd.
Express Pharma
January 2026

Express Pharma - January 2026

filled-star
Filter issues ✕
From Choose Date
To Choose Date
Express Pharma

Vuélvete ilimitado con Magzter GOLD

Leer Express Pharma junto con más de 9000 revistas y periódicos con una sola suscripción  

Ver catálogo

1 mes

$14.99

1 año

$149.99

$12/month

(OR)

Suscríbete sólo a Express Pharma

Comprar este número: January 2026

undefined problemas a partir de January 2026

12 números a partir de January 2026

Comprar este número

$0.99

1 año

$5.49

Please choose your subscription plan

Regalo Express Pharma

Cancelar en cualquier momento.

(Sin compromisos) ⓘ

Si no estás satisfecho con tu suscripción, puedes enviarnos un correo electrónico a help@magzter.com dentro de los 7 días posteriores a la fecha de inicio de la suscripción para recibir un reembolso completo. ¡Sin preguntas, lo prometemos! (Nota: No se aplica a compras de números individuales)

Suscripción digital

Acceso instantáneo ⓘ

Suscríbete ahora para comenzar a leer instantáneamente en el sitio web de Magzter, iOS, Android y las aplicaciones de Amazon.

Verificado seguro

pago ⓘ

Magzter es un comerciante verificado de Authorize.Net. Más información

En este número

India's Foremost Pharma & Biotech Magazine ~ India's Innovation Journey: From Promise To Proof

Pharcos Speciality's Daman plant secures WHO-GMP certification

The certification underscores Pharcos' adherence to globally recognised quality standards, safety, and regulatory compliance, strengthening its position as a trusted manufacturer of excipients

Pharcos Speciality's Daman plant secures WHO-GMP certification0

2 mins

Local manufacturing is not just a priority— it is a national commitment

Frehiwot Abebe, State Minister, Ministry of Health, Ethiopia, and Bhavin Mukund Mehta, Vice Chairman, Pharmexcil, discuss Ethiopia's evolving pharma ecosystem.

Local manufacturing is not just a priority— it is a national commitment1

4 mins

We are cost-competitive and aligned with global ESG framework demands

From dependence on imported single-use products and containment solutions, India's biologics sector can today access domestically manufactured SUTs, which can be 20–30 per cent more cost-effective than imported counterparts.

We are cost-competitive and aligned with global ESG framework demands2

5 mins

India at a jumping-off point in terms of commitment to global clinical studies

Paul Bridges, PhD, President, Consulting, Parexel, and Sanjay Vyas, President of Global Safety Services & Clinical Logistics and Country Head for India, Parexel, shortlist trends that will define 2026 from data protection uncertainty and AI governance to biosimilars' second wind, inspection readiness and India's emergence as a global clinical trials hub. Excerpts from a wide-ranging conversation with Viveka Roychowdhury

India at a jumping-off point in terms of commitment to global clinical studies3

6 mins

Supriya Lifescience ramps up capacity and global readiness for next phase of growth

Recently, Supriya Lifescience expanded its manufacturing capacity at the Lote facility with the commissioning of Module E, which has enhanced operational efficiency and increased capacity utilisation from 70 per cent in FY2025 to 78 per cent in the first half of FY 2026.

Supriya Lifescience ramps up capacity and global readiness for next phase of growth4

4 mins

Quality Trailblazer emphasises that leadership commitment is non-negotiable

In an exclusive interview with Swati Rana, Ranjit Barshikar, CEO - QbD International and author of the newly launched book Quality Trailblazer, shares reflections from his five-decade journey across global pharmaceutical manufacturing, quality systems, and regulatory landscapes

5 mins

Next year, resilience will bubble up as a critical business objective

As pharma R&D becomes more digital, cloud-driven and Al-enabled, cyber risk is fast emerging as a boardroom priority. Rajnish Gupta, MD & Country Manager, Tenable India, explains why resilience, not just prevention, will define pharma cybersecurity strategies in 2026 and beyond, in an interview with Viveka Roychowdhury

Next year, resilience will bubble up as a critical business objective6

4 mins

We train professionals to see quality not as a checklist but as a mindset

Prof. Dr Syed S. Abbas, Director, Institute of Good Manufacturing Practices India (IGMPI), explains how globally benchmarked programmes, hands-on learning, industry-aligned curricula, and flexible training models are preparing professionals to meet global compliance expectations and strengthen India's position as a hub for safe, high-quality pharma products, in an interaction with Kalyani Sharma

We train professionals to see quality not as a checklist but as a mindset7

4 mins

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

Results win customers. Leadership discipline keeps them8

3 mins

Leadership imperative shaping India's healthcare and pharma landscape in 2026

India's rapidly growing healthcare sector now needs a new kind of leadership-one that blends scientific expertise with strategic, ethical, and digital capabilities to remain globally competitive

Leadership imperative shaping India's healthcare and pharma landscape in 20269

3 mins

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF10

8 mins

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

Odisha's pharma pitch11

5 mins

Pharma trends that will shape 2026: Building a future-ready, patient-centric industry

Anil Matai, Director General, OPPI, outlines the major pharmaceutical trends expected to shape 2026, detailing how digital health, Al-driven drug development, precision medicine and resilient supply chains will influence the industry's shift towards a future-ready, patient-centric ecosystem

Pharma trends that will shape 2026: Building a future-ready, patient-centric industry12

3 mins

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

Can Indian biosimilars and generics restate accessibility in global underserved markets?13

3 mins

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers14

6 mins

Clinical research careers: India's next big opportunity

Dr Seema Pai, President, Indian Society for Clinical Research highlights that India's clinical research sector is rapidly growing, and this growth is creating global opportunities, fostering collaboration, and opening promising career pathways for young professionals while positioning India as a future leader in clinical research

Clinical research careers: India's next big opportunity15

3 mins

India's Pharma 2047: How academia can drive innovation and self-reliance

Dr Supriya Shidhaye, Principal, Vivekanand Education Society College of Pharmacy (Autonomous), asserts that pharmacy institutions must become catalysts of discovery, translational research, and high-value skill development. The future demands not just graduates, but innovators and leaders capable of shaping global healthcare

India's Pharma 2047: How academia can drive innovation and self-reliance16

3 mins

Beyond the ladder: Why sustainable growth needs to be T-shaped and self-driven

If one looks at the organisations that have excelled in their core operating areas and also considered as employers of choice, one will find that employee growth and development are deep rooted in the ethos of such organisations and act as strategic drivers for professional and organisational success.

Beyond the ladder: Why sustainable growth needs to be T-shaped and self-driven17

5 mins

Strategic procurement in clinical trials: A digital transformation imperative

Gourab Ray, Global Category Buyer, Sanofi outlines key value levers, describes an operating model that integrates procurement with clinical and supply-chain functions, and proposes a pragmatic roadmap for sponsors and CROs seeking to modernise their approach

Strategic procurement in clinical trials: A digital transformation imperative18

7 mins

Local focus to strengthen Indian pharmaceutical manufacturers

For the Indian pharmaceutical industry, competitiveness not only means access to international markets, but also establishing expertise and operational capabilities on an equal footing directly in India.

Local focus to strengthen Indian pharmaceutical manufacturers19

3 mins

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players20

6 mins

What It Takes to Build Pharmaceutical Facilities That Perform from Day One

As regulatory expectations tighten and speed-to-market pressures intensify, pharmaceutical facilities must be designed for certainty from day one. Drawing from large-scale project experience, engineering, simulation-led design, and early validation are redefining successful facility delivery

What It Takes to Build Pharmaceutical Facilities That Perform from Day One21

3 mins

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

Vizag rising: Shaping India's pharma future22

9 mins

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

Future of pharma: Trends, challenges & AI23

2 mins

Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero

In a post-pandemic world, pharma real estate has evolved from a cost decision to a strategic one.

Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero24

5 mins

Leveraging Microfluidic Technology for mRNA-LNP Manufacturing

Over the past five years, messenger RNA (mRNA) therapeutics have undergone a rapid transition from experimental tools to powerful, life-saving medicines. From vaccines to cancer immunotherapies, mRNA offers the ability to instruct our own cells to produce therapeutic proteins on demand.

Leveraging Microfluidic Technology for mRNA-LNP Manufacturing25

3 mins

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments26

1 mins

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

PRUV® -The original Sodium Stearyl Fumarate27

5 mins

Lea todas las historias de Express Pharma

Express Pharma Description:

Editor: The-Indian-Express-Ltd.

Categoría: Health

Idioma: English

Frecuencia: Monthly

Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994, published by one of the oldest and most respected media group in India, the Indian Express Group. Express Pharma is India’s foremost Pharma & Biotech publication, published in a handy size and an international format, designed for readers convenience. Organized into four sections – Market, Management, Research and Pharma Life, it caters to the information needs of all levels of the pharmaceutical and biotech professionals. EP offers the widest geographic reach, focused business segment coverage and the sure means to reach the senior management and decision makers across the Industry.

Ediciones recientes

Títulos relacionados

Categorías populares

Ver todo